|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0001560,
umls-concept:C0205210,
umls-concept:C0205263,
umls-concept:C0205462,
umls-concept:C0205483,
umls-concept:C0220912,
umls-concept:C0220913,
umls-concept:C0332307,
umls-concept:C0528649,
umls-concept:C0971858,
umls-concept:C1511646,
umls-concept:C1704410
|
|
pubmed:issue |
3
|
|
pubmed:dateCreated |
2000-4-7
|
|
pubmed:abstractText |
Human cartilage glycoprotein 39 (HC gp-39) was recently identified as a candidate autoantigen in the pathogenesis of rheumatoid arthritis. In the present studies, we investigated the capacity of HC gp-39 to interfere in clinical disease induced by an unrelated autoantigen, type II collagen (CII), by the induction of cross-tolerance.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Mar
|
|
pubmed:issn |
0004-3591
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
43
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
645-55
|
|
pubmed:dateRevised |
2011-11-17
|
|
pubmed:meshHeading |
pubmed-meshheading:10728759-Adipokines,
pubmed-meshheading:10728759-Administration, Intranasal,
pubmed-meshheading:10728759-Animals,
pubmed-meshheading:10728759-Antibodies,
pubmed-meshheading:10728759-Arthritis,
pubmed-meshheading:10728759-Collagen,
pubmed-meshheading:10728759-Down-Regulation,
pubmed-meshheading:10728759-Drug Tolerance,
pubmed-meshheading:10728759-Female,
pubmed-meshheading:10728759-Glycoproteins,
pubmed-meshheading:10728759-Humans,
pubmed-meshheading:10728759-Joints,
pubmed-meshheading:10728759-Lectins,
pubmed-meshheading:10728759-Mice,
pubmed-meshheading:10728759-Mice, Inbred BALB C,
pubmed-meshheading:10728759-Mice, Inbred DBA
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Induction of tolerance with intranasal administration of human cartilage gp-39 in DBA/1 mice: amelioration of clinical, histologic, and radiologic signs of type II collagen-induced arthritis.
|
|
pubmed:affiliation |
Department of Rheumatology, University Hospital Nijmegen, The Netherlands.
|
|
pubmed:publicationType |
Journal Article
|
